arrow
V

Valentin Dérangère

universite bourgogne europe
H指数:35
被引数:6,077

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort

晚期卵巢癌中同源重组缺陷的年龄相关分布:一项大型真实世界法国队列研究

2026-07-010
PRE
Chemo-prAIdict Breast: a deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

Chemo-prAIdict Breast:一种用于预测接受新辅助化疗的乳腺癌患者活检中残留疾病情况的深度学习解决方案。

2026-01-070
PRE
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer

癌源性IL-1β逆转非小细胞肺癌的化疗免疫疗法耐药性

2025-11-210
OAAI
Safety and efficacy of trifluridine/tipiracil plus /- bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial

三氟尿idine/替吡拉塞联合/或贝伐珠单抗联合XB2001(抗-IL-1α抗体)的安全性与有效性:一项单中心1期临床试验

2025-01-170
OA
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC
2024-08-070
OAAI
Machine learning evaluation of immune in fi ltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts

通过数字肿瘤评分对免疫功能进行机器学习评估,可以在三个国际III期结肠癌队列的汇总分析中预测生存结果

2024-07-010
OAAI
Deep learning uncovers morphological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients
2024-03-220
PRE
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

一线durvalumab和tremelimumab联合化疗治疗RAS突变的转移性结直肠癌: 1b/2期试验

2023-08-1034
OAAI
Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors
2022-09-0215
OAAI
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer
2022-09-017
PRE